Pharmacogenomics (PGx) isbecoming a cornerstone of precision medicine due to variations in drug safetyand efficacy attributed to an individual’s genetic profile.
Providence Genomics piloted PGxusing genome sequencing for 2,111 participants in its Geno4ME program.
Participants and theirproviders received a PGx report and pharmacist consultation, and those withactionable results received personalized medication action plans.
Findings were presented at the2023 American College of Medical Genetics and Genomics Annual Clinical GeneticsMeeting.
